Single App knock-in mouse models of Alzheimer’s disease

Saito, Takashi, Matsuba, Yukio, Mihira, Naomi, Takano, Jiro, Nilsson, Per, Itohara, Shigeyoshi, Iwata, Nobuhisa, Saido, Takaomi C·2014·Nature Neuroscience

Cited by (1,333)

Items 201–300 of 1,333

  1. Amyloid Accumulation Drives Proteome-wide Alterations in Mouse Models of Alzheimer’s Disease-like Pathology
    Savas, Jeffrey N., Wang, Yi-Zhi, DeNardo, Laura A., Martinez-Bartolome, Salvador, McClatchy, Daniel B., Hark, Timothy J., Shanks, Natalie F., Cozzolino, Kira A., Lavallée-Adam, Mathieu, Smukowski, Samuel N. et al. · 2017 · Cell Reports
  2. Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits
    Xu, Guilian, Ran, Yong, Fromholt, Susan E., Fu, Chunhua, Yachnis, Anthony T., Golde, Todd E., Borchelt, David R. · 2015 · Acta Neuropathologica Communications
  3. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer’s disease
    Sakakibara, Yasufumi, Sekiya, Michiko, Saito, Takashi, Saido, Takaomi C., Iijima, Koichi M. · 2019 · BMC Neuroscience
  4. An impaired intrinsic microglial clock system induces neuroinflammatory alterations in the early stage of amyloid precursor protein knock-in mouse brain
    Junjun Ni, Zhou Wu, Jie Meng, Takashi Saito, Takaomi C. Saido, Hong Qing, Hiroshi Nakanishi · 2019 · Journal of Neuroinflammation
  5. The two faces of synaptic failure in AppNL-G-F knock-in mice
    Amira Latif‐Hernandez, Victor Sabanov, Tariq Ahmed, Katleen Craessaerts, Takashi Saito, Takaomi C. Saido, Detlef Balschun · 2020 · Alzheimer s Research & Therapy
  6. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression
    Alejandro Ruiz‐Riquelme, Heather H. C. Lau, Erica Stuart, Adrienn N. Goczi, Zhilan Wang, Gerold Schmitt‐Ulms, Joel C. Watts · 2018 · Acta Neuropathologica Communications
  7. APP accumulates with presynaptic proteins around amyloid plaques: A role for presynaptic mechanisms in Alzheimer's disease?
    Jordà‐Siquier, Tomàs, Petrel, Melina, Kouskoff, Vladimir, Smailovic, Una, Cordelières, Fabrice, Frykman, Susanne, Müller, Ulrike, Mulle, Christophe, Barthet, Gaël · 2022 · Alzheimer's & Dementia
  8. Imaging of Reactive Astrogliosis by Positron Emission Tomography
    Ryuichi Harada, Shozo Furumoto, Yukitsuka Kudo, Kazuhiko Yanai, Victor L. Villemagne, Nobuyuki Okamura · 2022 · Frontiers in Neuroscience
  9. Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer’s Disease
    Yijun Xu, Ngan Pan Bennett Au, Chi Him Eddie Ma · 2022 · Frontiers in Aging Neuroscience
  10. T cell-mediated microglial activation triggers myelin pathology in a mouse model of amyloidosis
    Shreeya Kedia, Hao Ji, Ruoqing Feng, Peter Androvic, Lena Spieth, Lu Liu, Jonas Franz, Hanna Zdiarstek, Katrin Perez Anderson, Cem Kaboglu et al. · 2024 · Nature Neuroscience
  11. Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease
    Emanuele Brai, Noemi Alina Raio, Lavinia Auber Alberi · 2016 · Acta Neuropathologica Communications
  12. Neuronal p38α mediates synaptic and cognitive dysfunction in an Alzheimer’s mouse model by controlling β-amyloid production
    Sandra Colié, Sara Sarroca, Rocío Palenzuela, Idoia García, Ander Matheu, Rubén Corpas, Carlos G. Dotti, Jose Antonio Esteban, Coral Sanfeliu, Ángel R. Nebreda · 2017 · Scientific Reports
  13. The intellectual disability gene PQBP1 rescues Alzheimer’s disease pathology
    Hikari Tanaka, Kanoh Kondo, Xigui Chen, Hidenori Homma, Kazuhiko Tagawa, Aurélien Kerever, Shigeki Aoki, Takashi Saito, Takaomi C. Saido, Shin‐ichi Muramatsu et al. · 2018 · Molecular Psychiatry
  14. Targeting Microglia-Synapse Interactions in Alzheimer’s Disease
    Gaia Piccioni, Dalila Mango, Amira Saidi, Massimo Corbo, Robert Nisticò · 2021 · International Journal of Molecular Sciences
  15. PET imaging of colony-stimulating factor 1 receptor: A head-to-head comparison of a novel radioligand, 11 C-GW2580, and 11 C-CPPC, in mouse models of acute and chronic neuroinflammation and a rhesus monkey
    Xiaoyun Zhou, Bin Ji, Chie Seki, Yuji Nagai, Takafumi Minamimoto, Masayuki Fujinaga, Ming‐Rong Zhang, Takashi Saito, Takaomi C. Saido, Tetsuya Suhara et al. · 2021 · Journal of Cerebral Blood Flow & Metabolism
  16. Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits
    Larson, Megan E., Greimel, Susan J., Amar, Fatou, LaCroix, Michael, Boyle, Gabriel, Sherman, Mathew A., Schley, Hallie, Miel, Camille, Schneider, Julie A., Kayed, Rakez et al. · 2017 · Proceedings of the National Academy of Sciences
  17. Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
    Kiwami Kidana, Takuya Tatebe, Kaori Ito, Norikazu Hara, Akiyoshi Kakita, Takashi Saito, Sho Takatori, Yasuyoshi Ouchi, Takeshi Ikeuchi, Mitsuhiro Makino et al. · 2018 · EMBO Molecular Medicine
  18. Plaque contact and unimpaired Trem2 is required for the microglial response to amyloid pathology
    Jack I. Wood, Eugenia Wong, Ridwaan Joghee, Aya Balbaa, Karina S. Vitanova, Katie M. Stringer, Alison VanSchoiack, Stefan-Laural J. Phelan, Francesca Launchbury, Sneha Desai et al. · 2022 · Cell Reports
  19. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
    Reyes, Juan F., Ekmark-Léwen, Sara, Perdiki, Marina, Klingstedt, Therése, Hoffmann, Alana, Wiechec, Emilia, Nilsson, Per, Nilsson, K. Peter R., Alafuzoff, Irina, Ingelsson, Martin et al. · 2021 · Acta Neuropathologica Communications
  20. Reduction of mNAT1/hNAT2 Contributes to Cerebral Endothelial Necroptosis and Aβ Accumulation in Alzheimer’s Disease
    Chengyu Zou, Lauren Mifflin, Zhirui Hu, Tian Zhang, Bing Shan, Huibing Wang, Xin Xing, Hong Zhu, Xian Adiconis, Joshua Z. Levin et al. · 2020 · Cell Reports
  21. Pulse-Chase Proteomics of the App Knockin Mouse Models of Alzheimer’s Disease Reveals that Synaptic Dysfunction Originates in Presynaptic Terminals
    Timothy J. Hark, Nalini R. Rao, Charlotte Castillon, Tamara Basta, Samuel N. Smukowski, Huan Bao, Arun Upadhyay, Ewa K. Bomba-Warczak, Toshihiro Nomura, Eileen T O'Toole et al. · 2020 · Cell Systems
  22. GSK3β is involved in promoting Alzheimer’s disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor proteinNL-F/NL-F knock-in mice
    Muzhou Jiang, Xinwen Zhang, Xu Yan, Shinsuke Mizutani, Haruhiko Kashiwazaki, Junjun Ni, Zhou Wu · 2021 · Brain Behavior and Immunity
  23. Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
    Ranran Lu, Lijie Zhang, Xinling Yang · 2022 · Frontiers in Aging Neuroscience
  24. Spatial reversal learning defect coincides with hypersynchronous telencephalic BOLD functional connectivity in APPNL-F/NL-F knock-in mice
    Disha Shah, Amira Latif‐Hernandez, Bart De Strooper, Takashi Saito, Takaomi C. Saido, Marleen Verhoye, Rudi D’Hooge, Annemie Van der Linden · 2018 · Scientific Reports
  25. The AppNL-G-F mouse retina is a site for preclinical Alzheimer’s disease diagnosis and research
    Marjan Vandenabeele, Lien Veys, Sophie Lemmens, Xavier Hadoux, Géraldine Gelders, Luca Masin, Lutgarde Serneels, Jan Theunis, Takashi Saito, Takaomi C. Saido et al. · 2021 · Acta Neuropathologica Communications
  26. Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease
    Rajani, Rikesh M., Ellingford, Robert, Hellmuth, Mariam, Harris, Samuel S., Taso, Orjona S., Graykowski, David, Lam, Francesca Kar Wey, Arber, Charles, Fertan, Emre, Danial, John S. H. et al. · 2024 · PLOS Biology
  27. ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease
    Katherine R. Sadleir, Jelena Popović, Robert J. Vassar · 2018 · Journal of Biological Chemistry
  28. Photo-oxygenation by a biocompatible catalyst reduces amyloid-β levels in Alzheimer’s disease mice
    Shuta Ozawa, Yukiko Hori, Y. Shimizu, Atsuhiko Taniguchi, Takanobu Suzuki, Wenbo Wang, Yung Wen Chiu, Reiko Koike, Satoshi Yokoshima, Tohru Fukuyama et al. · 2021 · Brain
  29. Can mouse models mimic sporadic Alzheimer’s disease?
    Humpel, Christian, Foidl, BettinaM · 2020 · Neural Regeneration Research
  30. The Biology of Glial Cells and Their Complex Roles in Alzheimer’s Disease: New Opportunities in Therapy
    S. Nirzhor, R. Khan, S. Neelotpol · 2018 · Biomolecules
  31. Pyk2 Signaling through Graf1 and RhoA GTPase Is Required for Amyloid-β Oligomer-Triggered Synapse Loss
    Lee, Suho, Salazar, Santiago V., Cox, Timothy O., Strittmatter, Stephen M. · 2019 · The Journal of Neuroscience
  32. Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in AppNL-G-F/NL-G-F mice
    Emre, Ceren, Arroyo-García, Luis E., Do, Khanh V., Jun, Bokkyoo, Ohshima, Makiko, Alcalde, Silvia Gómez, Cothern, Megan L., Maioli, Silvia, Nilsson, Per, Hjorth, Erik et al. · 2022 · Communications Biology
  33. Concurrent cell type–specific isolation and profiling of mouse brains in inflammation and Alzheimer’s disease
    Daniel B. Swartzlander, Nicholas E. Propson, Ethan R. Roy, Takashi Saito, Takaomi C. Saido, Baiping Wang, Hui Zheng · 2018 · JCI Insight
  34. Modernization of Golgi staining techniques for high-resolution, 3-dimensional imaging of individual neurons
    Katlijn Vints, Dorien Vandael, Pieter Baatsen, Benjamin Pavie, Frank Vernaillen, Nikky Corthout, Vasily Rybakin, Sebastian Munck, Natalia V. Gounko · 2019 · Scientific Reports
  35. Targeting increased levels of APP in Down syndrome: Posiphen‐mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model
    Xu‐Qiao Chen, Ahmad Salehi, Matthew L. Pearn, Cassia Overk, Phuong D. Nguyen, Alexander M. Kleschevnikov, Maria L. Maccecchini, William Cary Mobley · 2020 · Alzheimer s & Dementia
  36. PLD3 gene and processing of APP
    Fazzari, Pietro, Horre, Katrien, Arranz, Amaia M., Frigerio, Carlo Sala, Saito, Takashi, Saido, Takaomi C., De Strooper, Bart · 2017 · Nature
  37. Base editing strategy for insertion of the A673T mutation in the APP gene to prevent the development of AD in vitro
    Antoine Guyon, Joël Rousseau, Francis-Gabriel Bégin, Tom Bertin, Gabriel Lamothe, Jacques P. Tremblay · 2021 · Molecular Therapy — Nucleic Acids
  38. Periodontal Infection Aggravates C1q-Mediated Microglial Activation and Synapse Pruning in Alzheimer’s Mice
    Xiaoxiao Hao, Zhaofei Li, Wei Li, Jannet Katz, Suzanne M. Michalek, Scott R. Barnum, Lucas D. Pozzo‐Miller, Takashi Saito, Takaomi C. Saido, Qin Wang et al. · 2022 · Frontiers in Immunology
  39. The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer’s Disease and Parkinson’s Disease and Models of Mild Cognitive Impairment
    Jeannie Hwang, Candice Estick, Uzoma S. Ikonne, David Butler, Morgan C. Pait, Lyndsie H Elliott, Sarah Ruiz, Kaitlan Smith, Katherine M. Rentschler, Cary T. Mundell et al. · 2019 · International Journal of Molecular Sciences
  40. Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases
    Gloria Biechele, Nicolai Franzmeier, Tanja Blume, Michael Ewers, José Medina-Luque, Florian Eckenweber, Christian Sacher, Leonie Beyer, François Ruch, Simon Lindner et al. · 2020 · Journal of Neuroinflammation
  41. Touchscreen cognitive testing: Cross-species translation and co-clinical trials in neurodegenerative and neuropsychiatric disease
    Daniel D. Palmer, Julie R. Dumont, Tyler D. Dexter, Marco A. M. Prado, Elizabeth C. Finger, Timothy J. Bussey, Lisa M. Saksida · 2021 · Neurobiology of Learning and Memory
  42. Alzheimer’s Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment
    T. NAKAI, Kiyofumi Yamada, Hiroyuki Mizoguchi · 2021 · International Journal of Molecular Sciences
  43. Microglia and CD206+ border-associated mouse macrophages maintain their embryonic origin during Alzheimer’s disease
    Xiaoting Wu, Takashi Saito, Takaomi C. Saido, Anna M. Barron, Christiane Ruedl · 2021 · eLife
  44. Generation of App knock-in mice reveals deletion mutations protective against Alzheimer’s disease-like pathology
    Kenichi Nagata, Mika Takahashi, Yukio Matsuba, Fumi Okuyama-Uchimura, Kaori Sato, Shoko Hashimoto, Takashi Saito, Takaomi C. Saido · 2018 · Nature Communications
  45. STAT3 inhibitor mitigates cerebral amyloid angiopathy and parenchymal amyloid plaques while improving cognitive functions and brain networks
    Jogender Mehla, Itender Singh, Deepti Diwan, James W. Nelson, Molly Lawrence, Eunjae Lee, Adam Q. Bauer, David M. Holtzman, Gregory Joseph Zipfel · 2021 · Acta Neuropathologica Communications
  46. Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model
    Jiqing Xu, Fred de Winter, Catherine Borna Farrokhi, Edward M. Rockenstein, Michael Mante, Anthony Adame, Jonathan R. Cook, Xin Jin, Eliezer Masliah, Kuo‐Fen Lee · 2016 · Scientific Reports
  47. Temporal progression of Alzheimer's disease in brains and intestines of transgenic mice
    Gunjan Dhawan Manocha, Angela Marie Floden, Nicole Miller, Abbie J. Smith, Kumi Nagamoto‐Combs, Takashi Saito, Takaomi C. Saido, Colin Kelly Combs · 2019 · Neurobiology of Aging
  48. Contribution of GABAergic interneurons to amyloid-β plaque pathology in an APP knock-in mouse model
    Heather C. Rice, Gabriele Marcassa, Iordana Chrysidou, Katrien Horré, Tracy L. Young‐Pearse, Ulrike Müller, Takashi Saito, Takaomi C. Saido, Robert J. Vassar, Joris de Wit et al. · 2020 · Molecular Neurodegeneration
  49. Stim2-Eb3 Association and Morphology of Dendritic Spines in Hippocampal Neurons
    Ekaterina I. Pchitskaya, Nina Kraskovskaya, Daria Chernyuk, Попугаева Елена Александровна, Hua Zhang, О. Л. Власова, Безпрозванный Илья Борисович · 2017 · Scientific Reports
  50. Neural functions of bisecting GlcNAc
    Yasuhiko Kizuka, Naoyuki Taniguchi · 2018 · Glycoconjugate Journal
  51. Consequences of Pharmacological BACE Inhibition on Synaptic Structure and Function
    Kaichuan Zhu, Finn Peters, Severin Filser, Jochen Wolfgang Herms · 2018 · Biological Psychiatry
  52. Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model
    Christian Sacher, Tanja Blume, Leonie Beyer, Finn Peters, Florian Eckenweber, Carmelo Sgobio, Maximilian Deußing, Nathalie L. Albert, Marcus Unterrainer, Simon Lindner et al. · 2019 · Journal of Nuclear Medicine
  53. Early Cognitive and Behavioral Deficits in Mouse Models for Tauopathy and Alzheimer’s Disease
    Celine Samaey, An Schreurs, Stijn Stroobants, Detlef Balschun · 2019 · Frontiers in Aging Neuroscience
  54. Alzheimer's therapy targeting the β-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies.
    M. Ohno · 2016 · Brain Research Bulletin
  55. Nucleic acid oxidative damage in Alzheimer's disease—explained by the hepcidin-ferroportin neuronal iron overload hypothesis?
    Tim Hofer, George L. Perry · 2016 · Journal of Trace Elements in Medicine and Biology
  56. Gamma oscillations in the entorhinal-hippocampal circuit underlying memory and dementia
    Tomoaki Nakazono, Heechul Jun, Mathew M. Blurton-Jones, Kim N. Green, Kei M. Igarashi · 2018 · Neuroscience Research
  57. SEQUIN Multiscale Imaging of Mammalian Central Synapses Reveals Loss of Synaptic Connectivity Resulting from Diffuse Traumatic Brain Injury
    Andrew D. Sauerbeck, Mihika Gangolli, Sydney J. Reitz, Maverick H. Salyards, Samuel Kim, Christopher Hemingway, Maud Gratuze, Tejaswi Makkapati, Martin Kerschensteiner, David M. Holtzman et al. · 2020 · Neuron
  58. Microglial circadian clock regulation of microglial structural complexity, dendritic spine density and inflammatory response
    Hiroshi Nakanishi, Junjun Ni, Saori Nonaka, Yoshinori Hayashi · 2020 · Neurochemistry International
  59. Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer’s disease
    Ting Wang, Akira Sobue, Seiji Watanabe, Okiru Komine, Takaomi C. Saido, Takashi Saito, Koji Yamanaka · 2024 · Journal of Neuroinflammation
  60. Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection
    Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta · 2024 · Neurochemistry International
  61. Circadian and Brain State Modulation of Network Hyperexcitability in Alzheimer’s Disease
    Rosalind Brown, Alice D. Lam, Alfredo Gonzalez‐Sulser, Andrew Ying, Mary Jones, Robert Chang-Chih Chou, Makis Tzioras, Crispin Y. Jordan, Izabela Jedrasiak-Cape, Anne-Laure Hemonnot-Girard et al. · 2018 · eNeuro
  62. Astrocyte and oligodendrocyte pathology in Alzheimer's disease
    Rania Ziar, Paul J. Tesar, Benjamin L.L. Clayton · 2025 · Neurotherapeutics
  63. The Alzheimer’s therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia
    Giulia Albertini, Magdalena Zielonka, Marie‐Lynn Cuypers, An Snellinx, Ciana Xu, Suresh Kumar Poovathingal, Marta Wojno, Kristofer Davie, Veerle van Lieshout, Katleen Craessaerts et al. · 2025 · Nature Neuroscience
  64. Intracerebral seeding of amyloid-β and tau pathology in mice: Factors underlying prion-like spreading and comparisons with α-synuclein
    Brendan B. McAllister, Sean G. Lacoursiere, Robert J. Sutherland, Majid H. Mohajerani · 2020 · Neuroscience & Biobehavioral Reviews
  65. Opposite changes in APP processing and human Aβ levels in rats carrying either a protective or a pathogenic APP mutation
    Marc D. Tambini, Kelly A. Norris, Luciano D'adamio · 2020 · eLife
  66. Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research
    Pádua, Mafalda Soares, Guil-Guerrero, José L., Prates, José A. M., Lopes, Paula Alexandra · 2024 · International Journal of Molecular Sciences
  67. Simultaneous detection of membrane contact dynamics and associated Ca2+ signals by reversible chemogenetic reporters
    Paloma García Casas, Michela Rossini, Linnéa Påvénius, Mezida B. Saeed, Nikita Arnst, Sonia Sonda, Tânia Fernandes, Irene D’Arsiè, Matteo Bruzzone, Valeria Berno et al. · 2024 · Nature Communications
  68. Lewy body dementia promotion by air pollutants
    Xiaodi Zhang, Haiqing Liu, Xiao Wu, Longgang Jia, Kundlik Gadhave, Lena Wang, Kevin Zhang, Hanyu Li, Rong Chen, Ramhari Kumbhar et al. · 2025 · Science
  69. Alzheimer’s Disease Model System Using Drosophila
    Leo Tsuda, Young‐Mi Lim · 2018 · Advances in experimental medicine and biology
  70. Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain
    Leon Stefanovski, Jil Mona Meier, Roopa Kalsank Pai, Paul Triebkorn, Tristram A. P. Lett, Leon Martin, Konstantin Bülau, Martin Hofmann‐Apitius, Ana Solodkin, Anthony Randal McIntosh et al. · 2021 · Frontiers in Neuroinformatics
  71. The in-tissue molecular architecture of β-amyloid pathology in the mammalian brain
    Conny Leistner, Martin Wilkinson, Ailidh Burgess, Charlie Alexander Lovatt, Stanley Goodbody, Yong Xu, Susan A. Deuchars, Sheena E. Radford, Neil A. Ranson, René A. W. Frank · 2023 · Nature Communications
  72. Astrocytes deficient in circadian clock gene Bmal1 show enhanced activation responses to amyloid-beta pathology without changing plaque burden
    Celia A. McKee, Jiyeon Lee, Yuqi Cai, Takashi Saito, Takaomi C. Saido, Erik S. Musiek · 2022 · Scientific Reports
  73. AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model
    Marika Marino, Lujia Zhou, Melvin Y. Rincón, Zsuzsanna Callaerts‐Vegh, Jens Verhaert, Jérôme Wahis, Eline Creemers, Lidia Yshii, Keimpe D. B. Wierda, Takashi Saito et al. · 2022 · EMBO Molecular Medicine
  74. Expression of the Alzheimer’s Disease Mutations AβPP695sw and PSEN1M146I in Double-Transgenic Göttingen Minipigs
    Jannik Ejnar Jakobsen, Marianne Johansen, Mette H. Schmidt, Ying Liu, Rong Li, Henrik Callesen, Margarita Melnikova, Mette Habekost, Carmela Matrone, Yvonne Bouter et al. · 2016 · Journal of Alzheimer s Disease
  75. High fat diet treatment impairs hippocampal long-term potentiation without alterations of the core neuropathological features of Alzheimer disease
    Isabel H. Salas, Akila Weerasekera, Tariq Ahmed, Zsuzsanna Callaerts‐Vegh, Uwe Himmelreich, Rudi D’Hooge, Detlef Balschun, Takaomi C. Saido, Bart De Strooper, Carlos G. Dotti · 2018 · Neurobiology of Disease
  76. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles
    Anurag Kumar Singh, Gaurav Mishra, Anand Maurya, Rajendra Awasthi, Komal Kumari, Abhimanyu Thakur, Arati Rai, Gopal Kumar Rai, Bhupesh Sharma, Giriraj Thirupathirao Kulkarni et al. · 2019 · Current Alzheimer Research
  77. Functional Neurophysiological Biomarkers of Early-Stage Alzheimer’s Disease: A Perspective of Network Hyperexcitability in Disease Progression
    Sean Tok, Abdallah Ahnaou, Wilhelmus H. I. M. Drinkenburg · 2021 · Journal of Alzheimer s Disease
  78. The dopaminergic system promotes neprilysin-mediated degradation of amyloid-β in the brain
    Naoto Watamura, Naomasa Kakiya, Ryo Fujioka, Naoko Kamano, Mika Takahashi, Per Nilsson, Takashi Saito, Nobuhisa Iwata, Shigeyoshi Fujisawa, Takaomi C. Saido · 2024 · Science Signaling
  79. Knowing the enemy: strategic targeting of complement to treat Alzheimer disease
    Andrea J. Tenner, Tiffany J. Petrisko · 2025 · Nature Reviews Neurology
  80. Alzheimer’s disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression
    Mickaël Audrain, Romain Roger Fol, P. Dutar, Brigitte Potier, Jean‐Marie Billard, Julien Flament, Sandro Alves, Marie‐Anne Burlot, Gaelle Dufayet‐Chaffaud, Alexis‐Pierre Bemelmans et al. · 2016 · Molecular Neurodegeneration
  81. Following spatial Aβ aggregation dynamics in evolving Alzheimer’s disease pathology by imaging stable isotope labeling kinetics
    Wojciech Michno, Katie M. Stringer, Thomas Enzlein, Melissa K. Passarelli, Stéphane Escrig, Karina S. Vitanova, Jack I. Wood, Kaj Blennow, Henrik Zetterberg, Anders Meibom et al. · 2021 · Science Advances
  82. NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load
    Theresa Pohlkamp, Xunde Xian, Connie Hau Yan Wong, Murat S. Durakoglugil, Gordon Chandler Werthmann, Takaomi C. Saido, Bret M. Evers, Charles L. White, Jade Connor, Robert E Hammer et al. · 2021 · eLife
  83. The retina: A window in which to view the pathogenesis of Alzheimer’s disease
    Jie Zhang, Lei Shi, Yong Shen · 2022 · Ageing Research Reviews
  84. Exploring advancements in early detection of Alzheimer's disease with molecular assays and animal models
    Paalki Sethi, Rakesh Bhaskar, Dr. Krishna Kumar Singh, Saurabh Gupta, Sung Soo Han, D Avinash, Mosleh Mohammad Abomughaid, Apurva Koul, Bindu Rani, Shampa Ghosh et al. · 2024 · Ageing Research Reviews
  85. Role of NRF2 in Pathogenesis of Alzheimer’s Disease
    Ching‐Tung Chu, Akira Uruno, Fumiki Katsuoka, Masayuki Yamamoto · 2024 · Antioxidants
  86. Dietary lipophilic iron alters amyloidogenesis and microglial morphology in Alzheimer's disease knock-in APP mice
    Douglas G. Peters, Alexis N. Pollack, Keith C. Cheng, Dongxiao Sun, Takaomi C. Saido, Michael Haaf, Qing X. Yang, James R. Connor, Mark D. Meadowcroft · 2018 · Metallomics
  87. Prenatal noise stress aggravates cognitive decline and the onset and progression of beta amyloid pathology in a mouse model of Alzheimer's disease
    Zahra Jafari, Megan Okuma, Hadil Karem, Jogender Mehla, Bryan E Kolb, Majid H. Mohajerani · 2019 · Neurobiology of Aging
  88. The effect of dietary fat consumption on Alzheimer’s disease pathogenesis in mouse models
    Anna Amelianchik, Lauren Sweetland-Martin, Erin H. Norris · 2022 · Translational Psychiatry
  89. Quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies
    Michael J. Morten, Liina Sirvio, Huzefa Rupawala, Emma Mee Hayes, Aitor Franco, Carola I. Radulescu, Liming Ying, Samuel J. Barnes, Arturo Muga, Yu Ye · 2022 · Proceedings of the National Academy of Sciences
  90. Parental origin of transgene modulates amyloid-β plaque burden in the 5xFAD mouse model of Alzheimer’s disease
    Sasmita, Andrew Octavian, Ong, Erinne Cherisse, Nazarenko, Taisiia, Mao, Shuying, Komarek, Lina, Thalmann, Maik, Hantakova, Veronika, Spieth, Lena, Berghoff, Stefan A., Barr, Helena J. et al. · 2025 · Neuron
  91. Brain Region-Specific Gene Signatures Revealed by Distinct Astrocyte Subpopulations Unveil Links to Glioma and Neurodegenerative Diseases
    Raquel Cuevas‐Díaz Durán, Chih-Yen Wang, Hui Zheng, Benjamin Deneen, Jia Qian Wu · 2019 · eNeuro
  92. Insoluble Aβ overexpression in an App knock-in mouse model alters microstructure and gamma oscillations in the prefrontal cortex, affecting anxiety-related behaviours
    Eleftheria Pervolaraki, Stephen P Hall, Denise Foresteire, Takashi Saito, Takaomi C. Saido, Miles A. Whittington, Colin Lever, James Dachtler · 2019 · Disease Models & Mechanisms
  93. Astaxanthin Ameliorated Parvalbumin-Positive Neuron Deficits and Alzheimer’s Disease-Related Pathological Progression in the Hippocampus of AppNL-G-F/NL-G-F Mice
    Nobuko Hongo, Yusaku Takamura, Hiroshi Nishimaru, Jumpei Matsumoto, Tobe Kazuyuki, Takashi Saito, Takaomi C. Saido, Hisao Nishijo · 2020 · Frontiers in Pharmacology
  94. Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases
    Kazuma Murakami, Naotaka Izuo, Gal Bitan · 2021 · Journal of Biological Chemistry
  95. Epigenetic repression of Wnt receptors in AD: a role for Sirtuin2-induced H4K16ac deacetylation of Frizzled1 and Frizzled7 promoters
    Ernest Palomer, Núria Martín‐Flores, Sarah Jolly, Patricia Pascual Vargas, Stefano Benvegnù, Marina Podpolny, Samuel Teo, Kadi Vaher, Takashi Saito, Takaomi C. Saido et al. · 2022 · Molecular Psychiatry
  96. Human and mouse proteomics reveals the shared pathways in Alzheimer’s disease and delayed protein turnover in the amyloidome
    Yarbro, Jay M., Han, Xian, Dasgupta, Abhijit, Yang, Ka, Liu, Danting, Shrestha, Him K., Zaman, Masihuz, Wang, Zhen, Yu, Kaiwen, Lee, Dong Geun et al. · 2025 · Nature Communications
  97. The gut–brain axis in Alzheimer’s disease is shaped by commensal gut microbiota derived extracellular vesicles
    Junhua Xie, Lien Van Hoecke, Elien Van Wonterghem, Griet Van Imschoot, Vanessa Andries, Lars Vereecke, Roosmarijn E. Vandenbroucke · 2025 · Gut Microbes
  98. Proteomic landscape of Alzheimer’s disease: emerging technologies, advances and insights (2021 – 2025)
    Jay M. Yarbro, Him K. Shrestha, Zhen Wang, Xue Zhang, Masihuz Zaman, Mengqi Chu, Xusheng Wang, Gang Yu, Junmin Peng · 2025 · Molecular Neurodegeneration
  99. Uses for humanised mouse models in precision medicine for neurodegenerative disease
    R. Nair, Silvia Corrochano, Samanta Gasco, Charlotte Tibbit, David Thompson, Cheryl Maduro, Zeinab Ali, Pietro Fratta, Abraham Acevedo‐Arozena, Thomas J. Cunningham et al. · 2019 · Mammalian Genome
  100. MUTYH Actively Contributes to Microglial Activation and Impaired Neurogenesis in the Pathogenesis of Alzheimer’s Disease
    Yuri Mizuno, Nona Abolhassani, Guianfranco Mazzei, Kunihiko Sakumi, Takashi Saito, Takaomi C. Saido, Toshiharu Ninomiya, Toru Iwaki, Ryo Yamasaki, Jun‐ichi Kira et al. · 2021 · Oxidative Medicine and Cellular Longevity